1. Home
  2. FCEL vs OBX Comparison

FCEL vs OBX Comparison

Compare FCEL & OBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FuelCell Energy Inc.

FCEL

FuelCell Energy Inc.

N/A

Current Price

$6.62

Market Cap

896.3M

Sector

Energy

ML Signal

N/A

Logo Obsidian Therapeutics Inc. Common Stock

OBX

Obsidian Therapeutics Inc. Common Stock

N/A

Current Price

$11.89

Market Cap

848.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FCEL
OBX
Founded
1969
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
896.3M
848.8M
IPO Year
2005
2026

Fundamental Metrics

Financial Performance
Metric
FCEL
OBX
Price
$6.62
$11.89
Analyst Decision
Buy
Strong Buy
Analyst Count
11
5
Target Price
$21.10
★ $38.67
AVG Volume (30 Days)
★ 4.9M
541.6K
Earning Date
12-17-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 5.24
N/A
EPS
★ N/A
N/A
Revenue
★ $89,437,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$62.37
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.71
$9.60
52 Week High
$37.88
$39.00

Technical Indicators

Market Signals
Indicator
FCEL
OBX
Relative Strength Index (RSI) 28.21 41.92
Support Level $6.18 $11.84
Resistance Level $7.31 $15.87
Average True Range (ATR) 0.93 1.60
MACD -0.16 -0.03
Stochastic Oscillator 1.58 42.68

Price Performance

Historical Comparison
FCEL
OBX

About FCEL FuelCell Energy Inc.

FuelCell Energy Inc is a clean energy technology company engaged in the development, design, production, and servicing of high temperature fuel cells for clean electric power generation. The Company provides proprietary molten carbonate fuel cell systems that generate electricity electrochemically with ultra low emissions and high efficiency, and operates as a solutions provider managing the design, manufacturing, installation, and maintenance of its systems under long term power purchase, service, and engineering procurement agreements. The Company serves utilities, data centers, and commercial and industrial customers, and operates in the United States, South Korea, Europe, and Canada, with maximum revenue generated from the United States.

About OBX Obsidian Therapeutics Inc. Common Stock

Obsidian Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor infiltrating lymphocytes (TIL) cell therapies for the treatment of patients with solid tumors. The company's proprietary cytoDRiVE platform is versatile and allows it to leverage drug responsive domains to control protein function, with its initial focus on TIL cell therapies developed from this platform (cytoTILs). The company's flagship product candidate, OBX-115, is a novel, genetically engineered, autologous TIL cell therapy currently in a Phase 2 clinical trial for the treatment of melanoma and a Phase 1 clinical trial for the treatment of non-small cell lung cancer.

Share on Social Networks: